Colocalization of the IL-12 Receptor and FcgammaRIIIa to Natural Killer Cell Lipid Rafts Leads to Activation of ERK and Enhanced Production of Interferon-gamma
Overview
Authors
Affiliations
Natural killer (NK) cells express an activating receptor for the Fc portion of IgG (FcgammaRIIIa) that mediates interferon (IFN)-gamma production in response to antibody (Ab)-coated targets. We have previously demonstrated that NK cells activated with interleukin-12 (IL-12) in the presence of immobilized IgG secrete 10-fold or more higher levels of IFN-gamma as compared with stimulation with either agent alone. We examined the intracellular signaling pathways responsible for this synergistic IFN-gamma production. NK cells costimulated via the FcR and the IL-12 receptor (IL-12R) exhibited enhanced levels of activated STAT4 and Syk as compared with NK cells stimulated through either receptor alone. Extracellular signal-regulated kinase (ERK) was also synergistically activated under these conditions. Studies with specific chemical inhibitors revealed that the activation of ERK was dependent on the activation of PI3-K, whose activation was dependent on Syk, and that sequential activation of these molecules was required for NK cell IFN-gamma production in response to FcR and IL-12 stimulation. Retroviral transfection of ERK1 into primary human NK cells substantially increased IFN-gamma production in response to immobilized IgG and IL-12, while transfection of human NK cells with a dominant-negative ERK1 abrogated IFN-gamma production. Confocal microscopy and cellular fractionation experiments revealed that FcgammaRIIIa and the IL-12R colocalized to areas of lipid raft microdomains in response to costimulation with IgG and IL-12. Chemical disruption of lipid rafts inhibited ERK signaling in response to costimulation and significantly inhibited IFN-gamma production. These data suggest that dual recruitment of FcgammaRIIIa and the IL-12R to lipid raft microdomains allows for enhanced activation of downstream signaling events that lead to IFN-gamma production.
Bryan A, You J, Li G, Kim J, Singh A, Morstein J J Biol Chem. 2021; 297(6):101411.
PMID: 34793834 PMC: 8661020. DOI: 10.1016/j.jbc.2021.101411.
Li W, Li M, Anthony S, Yu Y Sci Rep. 2021; 11(1):13430.
PMID: 34183758 PMC: 8238967. DOI: 10.1038/s41598-021-92910-9.
Antibody Conjugation of Fluorescent Nanodiamonds for Targeted Innate Immune Cell Activation.
Suarez-Kelly L, Sun S, Ren C, Rampersaud I, Albertson D, Duggan M ACS Appl Nano Mater. 2021; 4(3):3122-3139.
PMID: 34027313 PMC: 8136585. DOI: 10.1021/acsanm.1c00256.
Zhang T, Hu W, Chen W Front Immunol. 2021; 12:613185.
PMID: 33679752 PMC: 7933204. DOI: 10.3389/fimmu.2021.613185.
Impact of Plasma Membrane Domains on IgG Fc Receptor Function.
Kara S, Amon L, Luhr J, Nimmerjahn F, Dudziak D, Lux A Front Immunol. 2020; 11:1320.
PMID: 32714325 PMC: 7344230. DOI: 10.3389/fimmu.2020.01320.